{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T17:41:28Z","timestamp":1787938888899,"version":"build-2784847793"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Autoimmune gastritis (AIG) and autoimmune liver diseases (AILDs)\u2014including autoimmune hepatitis (AIH), primary biliary cholangitis (PBC), and primary sclerosing cholangitis (PSC)\u2014are chronic organ-specific immune-mediated disorders. While both conditions frequently co-occur with other autoimmune diseases, the prevalence, clinical overlap, and immunological associations between AIG and AILDs remain underexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the prevalence of AIG in patients with AILD and characterize the clinical, serological, and histopathological features of this overlap, to improve early detection and guide integrated management strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a prospective study on 104 patients with a confirmed diagnosis of AILD. All participants were screened for anti-parietal cell antibodies (APCA); those testing positive underwent upper gastrointestinal endoscopy and gastric biopsies. Histological assessment was based on the updated Sydney System, with evaluation of mucosal inflammation, glandular atrophy, and intestinal metaplasia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>APCA positivity was observed in 22.1% of AILD patients, with a female predominance (78.3%). The median age of AIG diagnosis in APCA-positive patients was 58 years. Among APCA-positive individuals, histological confirmation of AIG was achieved in 91.3%, with a high rate of intestinal metaplasia (95.7%) and variable OLGA stages of gastric atrophy. Comorbid autoimmune conditions were common, with 43.5% of APCA-positive patients also presenting with autoimmune thyroiditis. Notably, PBC was disproportionately represented in the APCA-positive subgroup (47.8%) compared to the overall cohort (39.0%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study highlights a clinically significant association between AIG and AILDs, particularly in patients with PBC and concurrent autoimmune conditions. Given the elevated risk of gastric mucosal atrophy and potential neoplastic transformation, targeted screening for AIG in AILD patients\u2014especially those with APCA positivity or thyroid autoimmunity\u2014should be considered. These findings underscore the importance of cross-specialty surveillance and open new avenues for research into shared immunopathogenic mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lay Summary<\/jats:title>\n                    <jats:p>This study found that a significant number of patients with autoimmune liver diseases, especially those with primary biliary cholangitis, also show signs of autoimmune gastritis. These results support the consideration of targeted screening for gastric involvement in selected patients to improve early detection and clinical management of associated complications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1628478","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T05:25:53Z","timestamp":1753421153000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Immunological and clinical overlap between autoimmune gastritis and autoimmune liver diseases: a prospective cohort study"],"prefix":"10.3389","volume":"16","author":[{"given":"Sara","family":"Massironi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Dispinzieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cristoferi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Vincenzo","family":"Lenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Gerussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Elvevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Bonfichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Di Sabatino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio","family":"Danese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Invernizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1053\/j.gastro.2024.01.049","article-title":"Immunopathogenesis of primary biliary cholangitis, primary sclerosing cholangitis and autoimmune hepatitis: themes and concepts","volume":"166","author":"Trivedi","year":"2024","journal-title":"Gastroenterology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/17474124.2025.2473490","article-title":"Cholestatic liver diseases: modern therapeutics","author":"McNally","year":"2025","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2024.12.041","article-title":"Update in clinical science: Autoimmune hepatitis","author":"Heneghan","year":"2025","journal-title":"J Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.reumae.2025.501812","article-title":"The immunological landscape of primary biliary cholangitis: Mechanisms and therapeutic prospects","author":"Ronca","year":"2025","journal-title":"Hepatology."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-024-07273-z","article-title":"Rheumatological diseases in patients with autoimmune hepatitis in a fourth level hospital in Bogot\u00e1 between 2013 and 2023","volume":"501812","author":"Alm\u00e1nzar Cort\u00e9s","year":"2025","journal-title":"Reumatol Clin (Engl Ed)."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-024-07273-z","article-title":"Clinical and laboratory characteristics of Sj\u00f6gren\u2019s syndrome-associated autoimmune liver disease: a real-world, 10-year retrospective study","volume":"44","author":"Liang","year":"2025","journal-title":"Clin Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"156815","DOI":"10.1016\/j.cyto.2024.156815","article-title":"Immune traits in combination with inflammatory proteins revealing the pathogenesis of autoimmune liver diseases: A Mendelian randomization study","volume":"185","author":"Wang","year":"2025","journal-title":"Cytokine."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.09.020","article-title":"Autoimmune liver disease, autoimmunity and liver transplantation","volume":"60","author":"Carbone","year":"2014","journal-title":"J Hepatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.049","article-title":"The diagnosis and clinical significance of polyautoimmunity","volume":"13","author":"Anaya","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2018.08.011","article-title":"The changing face of chronic autoimmune atrophic gastritis: an updated comprehensive perspective","volume":"18","author":"Massironi","year":"2019","journal-title":"Autoimmun Rev"},{"key":"B11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-020-0187-8","article-title":"Autoimmune gastritis","volume":"6","author":"Lenti","year":"2020","journal-title":"Nat Rev Dis Primers."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.048","article-title":"Diagnosis and classification of autoimmune gastritis","volume":"13","author":"Toh","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/ueg2.70012","article-title":"European consensus on malabsorption-UEG & SIGE, LGA, SPG, SRGH, CGS, ESPCG, EAGEN, ESPEN, and ESPGHAN. Part 1: definitions, clinical phenotypes, and diagnostic testing for malabsorption","author":"Lenti","year":"2025","journal-title":"United Eur Gastroenterol J"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/ueg2.70011","article-title":"European consensus on malabsorption-UEG & SIGE, LGA, SPG, SRGH, CGS, ESPCG, EAGEN, ESPEN, and ESPGHAN: part 2: screening, special populations, nutritional goals, supportive care, primary care perspective","author":"Lenti","year":"2025","journal-title":"United Eur Gastroenterol J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"103135","DOI":"10.1016\/j.autrev.2022.103135","article-title":"Autoimmune polyendocrine syndrome type 1: Clinical manifestations, pathogenetic features, and management approach","volume":"21","author":"Bj\u00f8rklund","year":"2022","journal-title":"Autoimmun Rev"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000002619","article-title":"Long-term natural history of autoimmune gastritis: results from a prospective monocentric series","volume":"119","author":"Miceli","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2023-329618","article-title":"Gastric cancer risk in autoimmune gastritis: evidence versus opinion","volume":"73","author":"Rugge","year":"2024","journal-title":"Gut"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-328345","article-title":"Unravelling the risk of developing gastric cancer in autoimmune gastritis","volume":"72","author":"Lenti","year":"2023","journal-title":"Gut."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v15.i8.1451","article-title":"Incidence and prevalence of gastric neuroendocrine tumors in patients with chronic atrophic autoimmune gastritis","volume":"15","author":"Massironi","year":"2023","journal-title":"World J Gastrointest Oncol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1053\/j.gastro.2021.06.078","article-title":"AGA clinical practice update on the diagnosis and management of atrophic gastritis: expert review","volume":"161","author":"Shah","year":"2021","journal-title":"Gastroenterology."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1055\/a-2529-5025","article-title":"Management of epithelial precancerous conditions and early neoplasia of the stomach (MAPS III): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG) and European Society of Pathology (ESP) Guideline update 2025","author":"Dinis-Ribeiro","year":"2025","journal-title":"Endoscopy"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000003350","article-title":"ACG clinical guideline: diagnosis and management of gastric premalignant conditions","author":"Morgan","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2017.05.003","article-title":"Multiplex autoantibody detection for autoimmune liver diseases and autoimmune gastritis","volume":"448","author":"Vanderlocht","year":"2017","journal-title":"J Immunol Methods"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-017-3599-4","article-title":"Gastrointestinal and liver lesions in primary childhood Sj\u00f6gren syndrome","volume":"36","author":"Kashiwagi","year":"2017","journal-title":"Clin Rheumatol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cppeds.2014.10.001","article-title":"The impact of immune dysregulation on the development of autoimmune gastrointestinal and liver disease","volume":"44","author":"Levine","year":"2014","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-014-0439-3","article-title":"Mechanisms of tissue injury in autoimmune liver diseases","volume":"36","author":"Liaskou","year":"2014","journal-title":"Semin Immunopathol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jaut.2013.07.004","article-title":"Novel insights into autoimmune liver diseases provided by genome-wide association studies","volume":"46","author":"Mells","year":"2013","journal-title":"J Autoimmun"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1097\/mcg.0b013e3181c74e0d","article-title":"Concurrent autoimmune diseases in patients with autoimmune hepatitis","volume":"44","author":"Teufel","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/mcg.0b013e3181d7b1ac","article-title":"Concurrent autoimmune thyroid diseases in patients with autoimmune hepatitis","volume":"44","author":"Efe","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199610000-00001","article-title":"Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994","volume":"20","author":"Dixon","year":"1996","journal-title":". Am J Surg Pathol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.gie.2023.09.003","article-title":"Association of endoscopic biopsy sampling methods with detection of precursor lesions of gastric cancer","volume":"99","author":"Moon","year":"2024","journal-title":"Gastrointest Endosc."},{"key":"B32","doi-asserted-by":"crossref","DOI":"10.1016\/j.dld.2024.08.017","article-title":"L. M. Autoimmune liver diseases and autoimmune atrophic gastritis: an overlooked association","volume-title":"Digestive and liver disease","author":"Mosciatti","year":""},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1159\/000529151","article-title":"A case of autoimmune gastritis and hepatitis with enlarging gastric polyps after reducing the dose of prednisolone","volume":"17","author":"Katsumata","year":"2023","journal-title":"Case Rep Gastroenterol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/s1056-8727(00)00059-3","article-title":"Autoimmune hepatitis, autoimmune gastritis, and gastric carcinoid in a type 1 diabetic patient: a case report","volume":"14","author":"De Block","year":"2000","journal-title":"J Diabetes Complications."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.80208","article-title":"Autoimmune gastritis complicated by primary biliary cholangitis: A report of two cases and literature review","volume":"17","author":"Toyoda","year":"2025","journal-title":"Cureus."},{"key":"B36","doi-asserted-by":"publisher","first-page":"005376","DOI":"10.12890\/2025_005376","article-title":"Autoimmune polyglandular syndrome type 3b: A key to diagnosing autoimmune gastritis and asymptomatic primary biliary cholangitis","volume":"12","author":"Mabuchi","year":"2025","journal-title":"Eur J Case Rep Intern Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2012.06.004","article-title":"Factors associated with parietal cell autoantibodies in the general population","volume":"147","author":"Cabrera de Le\u00f3n","year":"2012","journal-title":"Immunol Lett"},{"key":"B38","doi-asserted-by":"publisher","first-page":"6152","DOI":"10.3390\/jcm12196152","article-title":"Increased prevalence of autoimmune gastritis in patients with a gastric precancerous lesion","volume":"12","author":"Guo","year":"2023","journal-title":"J Clin Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.1.82","article-title":"Autoimmune gastropathy in type 1 diabetic patients with parietal cell antibodies: histological and clinical findings","volume":"26","author":"De Block","year":"2003","journal-title":"Diabetes Care"},{"key":"B40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ejim.2016.03.025","article-title":"Polyautoimmunity in autoimmune gastritis","volume":"31","author":"Kalkan","year":"2016","journal-title":"Eur J Intern Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2007.09.025","article-title":"Occurrence and risk factors for autoimmune thyroid disease in patients with atrophic body gastritis","volume":"121","author":"Lahner","year":"2008","journal-title":"Am J Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2010.08.006","article-title":"Autoantibodies to parietal cells as predictors of atrophic body gastritis: a five-year prospective study in patients with autoimmune thyroid diseases","volume":"10","author":"Tozzoli","year":"2010","journal-title":"Autoimmun Rev"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1111\/j.1478-3231.2010.02281.x","article-title":"The possible link between the thyroid and autoimmune liver diseases","author":"Efe","year":"2010","journal-title":"Liver Int"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2019.1710766","article-title":"Relationship between autoimmune liver disease and autoimmune thyroid disease: a cross-sectional study","volume":"55","author":"Zeng","year":"2020","journal-title":"Scand J Gastroenterol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2009.12.012","article-title":"Prevalence of gastric parietal cell antibodies and intrinsic factor antibodies in primary biliary cirrhosis","volume":"411","author":"Liaskos","year":"2010","journal-title":"Clin Chim Acta"},{"key":"B46","doi-asserted-by":"publisher","first-page":"101373","DOI":"10.1016\/j.beem.2019.101373","article-title":"Thyro-entero-gastric autoimmunity: Pathophysiology and implications for patient management","volume":"34","author":"Lahner","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00092","article-title":"Hashimoto\u2019s thyroiditis and autoimmune gastritis","volume":"8","author":"Cellini","year":"2017","journal-title":"Front Endocrinol (Lausanne)."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2020-0615-oa","article-title":"Features that aid identification of autoimmune gastritis in a background of active helicobacter pylori infection","volume":"145","author":"Choudhuri","year":"2021","journal-title":"Arch Pathol Lab Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000002619","article-title":"Long-term natural history of autoimmune gastritis: results from a prospective, monocentric series","volume":"119","author":"Hong","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.3390\/jcm12031062","article-title":"Incidence of gastric neoplasms arising from autoimmune metaplastic atrophic gastritis: A systematic review and case reports","volume":"12","author":"Chen","year":"2023","journal-title":"J Clin Med"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000862","article-title":"Clinical and endoscopic-histological features of multifocal and corpus-restricted atrophic gastritis patients with non-cardia gastric cancer or dysplasia: A multicenter, cross-sectional study","author":"Lahner","year":"2025","journal-title":"Clin Transl Gastroenterol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.endonu.2009.11.001","article-title":"Prevalence and predictive factors of parietal cell antibody positivity in autoimmune thyroid disease","volume":"57","author":"Garc\u00eda Garc\u00eda","year":"2010","journal-title":"Endocrinol Nutr"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1628478\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T05:25:54Z","timestamp":1753421154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1628478\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":52,"alternative-id":["10.3389\/fimmu.2025.1628478"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1628478","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"article-number":"1628478"}}